These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 2615159)

  • 1. [Effect of diltiazem on the functional activity of erythrocytes and thrombocytes in patients with ischemic heart disease].
    Razumov VB; Gutkin AB; Leonova MV; Khudiakova ND
    Kardiologiia; 1989 Oct; 29(10):54-6. PubMed ID: 2615159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Various aspects of the anti-aggregatory action of diltiazem and cordaphene in patients with ischemic heart disease].
    Leonova MV; Rumiantsev DO; Belousov IuB
    Kardiologiia; 1991 Mar; 31(3):13-6. PubMed ID: 1875587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The role of erythrocytes in the pathogenesis of functional disorders of blood platelets in patients with ischemic heart disease and the possibilities of their pharmacological correction].
    Leonova MV; Razumov VB
    Kardiologiia; 1990 Apr; 30(4):107-11. PubMed ID: 2203926
    [No Abstract]   [Full Text] [Related]  

  • 4. [Characteristics of dilzem treatment of patients with ischemic heart disease].
    Zharov EI; Styrova TK; Martynov AI; Barinov VG; Makarovskiĭ VV; Vertkin AL; Sedov VP; Galichenko IV
    Kardiologiia; 1990 Dec; 30(12):30-3. PubMed ID: 2097392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of verapamil on the functional status of thrombocytes in patients with ischemic heart disease].
    Belousov IuB; Azizova OA; Razumov VB; Gutkin AB; Borin ML
    Kardiologiia; 1989 Feb; 29(2):42-5. PubMed ID: 2724766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Diltiazem and modulation of platelet aggregation].
    Colica G; Salnitro D; Scopelliti F; Sergi D; Pellegrino R; Zoccali A; Lanucara P
    Minerva Cardioangiol; 1990; 38(1-2):51-4. PubMed ID: 2342647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between endothelial dysfunction, oxidant stress and aspirin resistance in patients with stable coronary heart disease.
    Cheng G; Shan J; Xu G; Liu P; Zhou Y; Zhu Y; Lu X
    J Clin Pharm Ther; 2007 Jun; 32(3):287-92. PubMed ID: 17489881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Platelet aggregation in patients with coronary disease treated with nifedipine].
    Tkaczewski W; Goch JH; Kruszyński G; Ryniec A
    Pol Tyg Lek; 1990 Mar 5-12; 45(10-11):219-21. PubMed ID: 2216944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Ca2+-antagonistic vasodilators, diltiazem, nifedipine, perhexiline and verapamil, on platelet aggregation in vitro.
    Ono H; Kimura M
    Arzneimittelforschung; 1981; 31(7):1131-4. PubMed ID: 7196762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Characteristics of nicardipine treatment of patients with ischemic heart disease].
    Zharov EI; Makarovskiĭ VV; Styrova TK; Galichenko IV; Barinov VG; Martynov AI; Vertkin AL
    Kardiologiia; 1991 Mar; 31(3):16-8. PubMed ID: 1875588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Calcium metabolism of the thrombocytes in ischemic heart disease].
    Kiktev VG; Men'shikov MIu; Bugriĭ EM; Kuz'min AV; Karpov IuA
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1988; 11(2):58-61. PubMed ID: 3233156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Free cytoplasmic calcium and thrombocyte aggregation in patients with ischemic heart disease. The effect of ADP, thrombocyte activation factor and serotonin].
    Panchenko EP; Shalaev SV; Men'shikov MIu; Tkachuk VA; Gratsianskiĭ NA
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1986; 9(2):90-6. PubMed ID: 3801147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in platelet response to adenosine 5'-diphosphate caused by verapamil.
    Walkowiak B; Koziołkiewicz W; Michalec L; Pawłowska Z; Krzesłowska J; Cierniewski CS
    Pol J Pharmacol; 1996; 48(3):303-5. PubMed ID: 9112667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of red blood cells on the ADP-induced aggregation of human platelets in flow through tubes.
    Bell DN; Spain S; Goldsmith HL
    Thromb Haemost; 1990 Feb; 63(1):112-21. PubMed ID: 2339347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of platelet aggregation by diltiazem. Comparison with verapamil and nifedipine and inhibitory potencies of diltiazem metabolites.
    Kiyomoto A; Sasaki Y; Odawara A; Morita T
    Circ Res; 1983 Feb; 52(2 Pt 2):I115-9. PubMed ID: 6831645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of Soviet-made prostaglandin E1 on the aggregation of thrombocytes and erythrocytes].
    Lakin KM; Makarov VA; Ovnatanova MS; Azhgikhin IS
    Farmakol Toksikol; 1976; 39(4):436-40. PubMed ID: 1027569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitory effects of diltiazem on platelet activation caused by ionophore A23187 plus ADP or epinephrine in subthreshold concentrations.
    Mehta P; Mehta J; Ostrowski N; Brigmon L
    J Lab Clin Med; 1983 Sep; 102(3):332-9. PubMed ID: 6411841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet aggregation induced by ADP from unsheared erythrocytes at physiological Ca++-concentration.
    Aursnes I; Gjesdal K; Abildgaard U
    Br J Haematol; 1981 Jan; 47(1):149-52. PubMed ID: 7437341
    [No Abstract]   [Full Text] [Related]  

  • 19. Diltiazem inhibits the spontaneous platelet aggregation in essential hypertension.
    Pechán J; Okrucká A
    Cardiology; 1991; 79(2):116-9. PubMed ID: 1834333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Characteristics of the treatment of ischemic heart disease with delayed-action verapamil].
    Zharov EI; Styrova TK; Barinov VG; Martynov AI; Galichenko IV; Sedov VP; Vertkin AL
    Klin Med (Mosk); 1991 Aug; 69(8):48-50. PubMed ID: 1791709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.